Jamie Bates

机构：Gilead Sciences (United States) · ORCID：0000-0001-9535-5661

发表论文 37 篇 · 总被引 1477 次 · h-index 11

代表论文

• Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma (2018 · Cell Metabolism · 被引 420)
• Acetyl‐CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents (2018 · Hepatology · 被引 260)
• Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation (2020 · Journal of Hepatology · 被引 230)
• Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response (2025 · Molecular Cancer · 被引 67)
• Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors (2021 · Science Translational Medicine · 被引 25)
• Targeting lipid biosynthesis pathways for hepatitis B virus cure (2022 · PLoS ONE · 被引 19)